Speakers at RIWC 2020

Kapil Bharti
Senior Investigator, National Eye Institute Adjunct Group Leader, NCATS National Institutes of health
Topic: FDA approved use of iPSC-derived RPE for dry AMD.

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace and repair dying cells in retina

NEI launches iPS cell therapy trial for dry AMD

Marius Ueffing, Professor, Dr. rer.nat.
Head of the Division of Molecular Biology of Retinal Degenerations, Head of the Core Facility for Medical Bioanalytics, Director of the Institute for Ophthalmic Research.

Topic: Systems Level Investigation on AMD: Insights from the European Eye-Risk Project

Read more about Marius

Elise Heon, MD, FRCS(C)

Dr. Héon is an Ophthalmologist and the Henry Brent Chair in Innovative Pediatric Ophthalmology Research.

Topic: Pediatric specificities in trials

Read more about Elise